Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dollar General Corp. (DG) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance

Dollar General Corp.Trade
Edwards Lifesciences Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Dollar General Corp. vs Edwards Lifesciences Corporation Common Stock — how do they compare? Dollar General Corp. trades at $124.27 (market cap $27.42B), while Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Dollar General Corp. pays a 1.9% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

DGEW
Market Cap
$27.42B$48.56B
Volume
2,291,5176,520,488
Sector
Consumer StaplesHealth
52-Week High
$156.26$95.18
52-Week Low
$95.94$72.65
Typical Hold Time
59 Days—
Enterprise Value
$41.60B$45.01B
Dividend Yield
1.9%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dollar General Corp.

DG trades at $122.16, down 0.89% on the day, with a neutral technical signal. The stock shows strong profitability with a 19.69% ROE and has beaten earnings estimates for the last three quarters. Recent news highlights margin benefits from tariff refunds and expansion of delivery services through Instacart. Cash flow from operations improved to $3.0 billion in 2025, supporting financial stability.

The outlook is positive with a consensus price target of $137.27, implying over 12% upside. Risks include competitive pressures and potential consumer spending weakness. Analyst sentiment is bullish with 55.77% buy ratings, but net income margin compression from 7.01% in 2022 to 2.77% in 2025 warrants monitoring.

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Dollar General Corp.

A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.

Read more on DG →

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →